[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Umbilical vein endothelial cell;
DOI=10.1074/jbc.271.47.29659; PubMed=8939898 [NCBI, ExPASy, EBI, Israel, Japan]
Kokame K.,
Kato H.,
Miyata T.;
"Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes.";
J. Biol. Chem. 271:29659-29665(1996).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=9251681 [NCBI, ExPASy, EBI, Israel, Japan]
van Belzen N.,
Dinjens W.N.M.,
Diesveld M.P.G.,
Groen N.A.,
van der Made A.C.J.,
Nozawa Y.,
Vlietstra R.,
Trapman J.,
Bosman F.T.;
"A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms.";
Lab. Invest. 77:85-92(1997).
|
[3]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Lung;
PubMed=9605764 [NCBI, ExPASy, EBI, Israel, Japan]
Zhou D.,
Salnikow K.,
Costa M.;
"Cap43, a novel gene specifically induced by Ni2+ compounds.";
Cancer Res. 58:2182-2189(1998).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1016/S0167-4889(99)00056-7; PubMed=10395947 [NCBI, ExPASy, EBI, Israel, Japan]
Piquemal D.,
Joulia D.,
Balaguer P.,
Basset A.,
Marti J.,
Commes T.;
"Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells.";
Biochim. Biophys. Acta 1450:364-373(1999).
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04406; PubMed=16421571 [NCBI, ExPASy, EBI, Israel, Japan]
Nusbaum C.,
Mikkelsen T.S.,
Zody M.C.,
Asakawa S.,
Taudien S.,
Garber M.,
Kodira C.D.,
Schueler M.G.,
Shimizu A.,
Whittaker C.A.,
Chang J.L.,
Cuomo C.A.,
Dewar K.,
FitzGerald M.G.,
Yang X.,
Allen N.R.,
Anderson S.,
Asakawa T.,
Blechschmidt K.,
Bloom T.,
Borowsky M.L.,
Butler J.,
Cook A.,
Corum B.,
DeArellano K.,
DeCaprio D.,
Dooley K.T.,
Dorris L. III,
Engels R.,
Gloeckner G.,
Hafez N.,
Hagopian D.S.,
Hall J.L.,
Ishikawa S.K.,
Jaffe D.B.,
Kamat A.,
Kudoh J.,
Lehmann R.,
Lokitsang T.,
Macdonald P.,
Major J.E.,
Matthews C.D.,
Mauceli E.,
Menzel U.,
Mihalev A.H.,
Minoshima S.,
Murayama Y.,
Naylor J.W.,
Nicol R.,
Nguyen C.,
O'Leary S.B.,
O'Neill K.,
Parker S.C.J.,
Polley A.,
Raymond C.K.,
Reichwald K.,
Rodriguez J.,
Sasaki T.,
Schilhabel M.,
Siddiqui R.,
Smith C.L.,
Sneddon T.P.,
Talamas J.A.,
Tenzin P.,
Topham K.,
Venkataraman V.,
Wen G.,
Yamazaki S.,
Young S.K.,
Zeng Q.,
Zimmer A.R.,
Rosenthal A.,
Birren B.W.,
Platzer M.,
Shimizu N.,
Lander E.S.;
"DNA sequence and analysis of human chromosome 8.";
Nature 439:331-335(2006).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Kidney;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan] The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[7]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 1-21.
TISSUE=Brain;
Angelicheva D.,
Kalaydjieva L.;
Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
|
[8]
|
FUNCTION.
PubMed=9766676 [NCBI, ExPASy, EBI, Israel, Japan]
Kurdistani S.K.,
Arizti P.,
Reimer C.L.,
Sugrue M.M.,
Aaronson S.A.,
Lee S.W.;
"Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.";
Cancer Res. 58:4439-4444(1998).
|
[9]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319; SER-330 AND SER-336, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1073/pnas.0404720101; PubMed=15302935 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Jedrychowski M.,
Schwartz D.,
Elias J.E.,
Villen J.,
Li J.,
Cohn M.A.,
Cantley L.C.,
Gygi S.P.;
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
|
[10]
|
INVOLVEMENT IN CMT4D.
DOI=10.1086/302978; PubMed=10831399 [NCBI, ExPASy, EBI, Israel, Japan]
Kalaydjieva L.,
Gresham D.,
Gooding R.,
Heather L.,
Baas F.,
de Jonge R.,
Blechschmidt K.,
Angelicheva D.,
Chandler D.,
Worsley P.,
Rosenthal A.,
King R.H.M.,
Thomas P.K.;
"N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom.";
Am. J. Hum. Genet. 67:47-58(2000).
|
[11]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; THR-328 AND SER-330, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1016/j.cell.2006.09.026; PubMed=17081983 [NCBI, ExPASy, EBI, Israel, Japan]
Olsen J.V.,
Blagoev B.,
Gnad F.,
Macek B.,
Kumar C.,
Mortensen P.,
Mann M.;
"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.";
Cell 127:635-648(2006).
|
[12]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330, AND MASS SPECTROMETRY.
TISSUE=Epithelium;
DOI=10.1038/nbt1240; PubMed=16964243 [NCBI, ExPASy, EBI, Israel, Japan]
Beausoleil S.A.,
Villen J.,
Gerber S.A.,
Rush J.,
Gygi S.P.;
"A probability-based approach for high-throughput protein phosphorylation analysis and site localization.";
Nat. Biotechnol. 24:1285-1292(2006).
|
[13]
|
PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-366, AND MASS SPECTROMETRY.
DOI=10.1002/elps.200600782; PubMed=17487921 [NCBI, ExPASy, EBI, Israel, Japan]
Giorgianni F.,
Zhao Y.,
Desiderio D.M.,
Beranova-Giorgianni S.;
"Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line.";
Electrophoresis 28:2027-2034(2007).
|
|
- FUNCTION: May have a growth inhibitory role.
- INTERACTION:
O95573:ACSL3; NbExp=1; IntAct=EBI-716486, EBI-1190822;
P63261:ACTG1; NbExp=1; IntAct=EBI-716486, EBI-351292;
Q9Y6Q5-1:AP1M2; NbExp=1; IntAct=EBI-716486, EBI-752259;
Q96CW1:AP2M1; NbExp=1; IntAct=EBI-716486, EBI-297683;
P05023:ATP1A1; NbExp=1; IntAct=EBI-716486, EBI-358778;
P27824:CANX; NbExp=2; IntAct=EBI-716486, EBI-355947;
Q00610:CLTC; NbExp=1; IntAct=EBI-716486, EBI-354967;
Q96KP4:CNDP2; NbExp=1; IntAct=EBI-716486, EBI-1190734;
P35606:COPB2; NbExp=1; IntAct=EBI-716486, EBI-1056534;
P35222-1:CTNNB1; NbExp=1; IntAct=EBI-716486, EBI-491563;
P14868:DARS; NbExp=1; IntAct=EBI-716486, EBI-358730;
Q92499:DDX1; NbExp=1; IntAct=EBI-716486, EBI-358474;
P17844:DDX5; NbExp=1; IntAct=EBI-716486, EBI-351962;
P36957:DLST; NbExp=1; IntAct=EBI-716486, EBI-351007;
P26641:EEF1G; NbExp=1; IntAct=EBI-716486, EBI-351467;
P13639:EEF2; NbExp=1; IntAct=EBI-716486, EBI-352560;
P41091:EIF2S3; NbExp=1; IntAct=EBI-716486, EBI-1054228;
P60228:EIF3S6; NbExp=1; IntAct=EBI-716486, EBI-347740;
Q01844:EWSR1; NbExp=1; IntAct=EBI-716486, EBI-739737;
P49327:FASN; NbExp=1; IntAct=EBI-716486, EBI-356658;
P52597:HNRPF; NbExp=1; IntAct=EBI-716486, EBI-352986;
P31943:HNRPH1; NbExp=1; IntAct=EBI-716486, EBI-351590;
Q00839:HNRPU; NbExp=1; IntAct=EBI-716486, EBI-351126;
P51659:HSD17B4; NbExp=1; IntAct=EBI-716486, EBI-358398;
P07900:HSP90AA1; NbExp=1; IntAct=EBI-716486, EBI-296047;
P11021:HSPA5; NbExp=1; IntAct=EBI-716486, EBI-354921;
Q12906-5:ILF3; NbExp=1; IntAct=EBI-716486, EBI-288405;
P33176:KIF5B; NbExp=1; IntAct=EBI-716486, EBI-355878;
P00338-1:LDHA; NbExp=1; IntAct=EBI-716486, EBI-681495;
P21397:MAOA; NbExp=1; IntAct=EBI-716486, EBI-1190845;
P08473:MME; NbExp=1; IntAct=EBI-716486, EBI-353759;
P19338:NCL; NbExp=1; IntAct=EBI-716486, EBI-352553;
P11940:PABPC1; NbExp=1; IntAct=EBI-716486, EBI-81531;
P14618:PKM2; NbExp=1; IntAct=EBI-716486, EBI-353408;
P63151:PPP2R2A; NbExp=1; IntAct=EBI-716486, EBI-1048931;
P35998:PSMC2; NbExp=1; IntAct=EBI-716486, EBI-359710;
P17980:PSMC3; NbExp=1; IntAct=EBI-716486, EBI-359720;
Q13200:PSMD2; NbExp=1; IntAct=EBI-716486, EBI-357648;
P83731:RPL24; NbExp=1; IntAct=EBI-716486, EBI-353146;
P39023:RPL3; NbExp=1; IntAct=EBI-716486, EBI-1056348;
P36578:RPL4; NbExp=1; IntAct=EBI-716486, EBI-348313;
P04844:RPN2; NbExp=1; IntAct=EBI-716486, EBI-719731;
P62249:RPS16; NbExp=1; IntAct=EBI-716486, EBI-352480;
P60866:RPS20; NbExp=1; IntAct=EBI-716486, EBI-353105;
P62854:RPS26; NbExp=1; IntAct=EBI-716486, EBI-353438;
P23396:RPS3; NbExp=1; IntAct=EBI-716486, EBI-351193;
P62753:RPS6; NbExp=1; IntAct=EBI-716486, EBI-356625;
P62241:RPS8; NbExp=1; IntAct=EBI-716486, EBI-351811;
P46781:RPS9; NbExp=1; IntAct=EBI-716486, EBI-351206;
Q9Y230:RUVBL2; NbExp=1; IntAct=EBI-716486, EBI-352939;
Q15436:SEC23A; NbExp=1; IntAct=EBI-716486, EBI-81088;
P34897:SHMT2; NbExp=1; IntAct=EBI-716486, EBI-352908;
P12236:SLC25A6; NbExp=1; IntAct=EBI-716486, EBI-356254;
P26639:TARS; NbExp=1; IntAct=EBI-716486, EBI-1042683;
Q04726-1:TLE3; NbExp=1; IntAct=EBI-716486, EBI-1052074;
Q92900:UPF1; NbExp=1; IntAct=EBI-716486, EBI-373471;
P55072:VCP; NbExp=1; IntAct=EBI-716486, EBI-355164;
P12956:XRCC6; NbExp=2; IntAct=EBI-716486, EBI-353208;
- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane. Note=Whereas in prostate epithelium and placental chorion it is located in both the cytoplasm and the nucleus, nuclear staining is not observed in colon epithelium cells. Instead its localization changes from the cytoplasm to the plasma membrane during differentiation of colon carcinoma cell lines in vitro.
- TISSUE SPECIFICITY: Ubiquitous; expressed most prominently in placental membranes and prostate, kidney, small intestine, and ovary tissues. Reduced expression in adenocarcinomas compared to normal tissues. In colon, prostate and placental membranes, the cells that border the lumen show the highest expression.
- INDUCTION: By homocysteine, 2-mercaptoethanol, tunicamycin in endothelial cells. Induced approximately 20-fold during in vitro differentiation of the colon carcinoma cell lines HT29-D4 and Caco-2. Induced by nickel compounds in all tested cell lines. The primary signal for its induction is an elevation of free intracellular calcium ion caused by nickel ion exposure. Okadaic acid, a serine/threonine phosphatase inhibitor, induced its expression more rapidly and more efficiently than nickel.
- DISEASE: Defects in NDRG1 are the cause of Charcot-Marie-Tooth disease type 4D (CMT4D) [MIM:601455]; also known as hereditary motor and sensory neuropathy Lom type (HMSNL). CMT4D is a recessive form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy and primary peripheral axonal neuropathy. Demyelinating CMT neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention, autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4.
- SIMILARITY: Belongs to the NDRG family.
- WEB RESOURCE: Name=GeneReviews; URL="http://www.genetests.org/query?gene=NDRG1";.
|